Hunan Fangsheng Pharm Co Ltd Asset Resilience Ratio

Latest as of June 2026: 2.43%

Hunan Fangsheng Pharm Co Ltd asset resilience ratio. Hunan Fangsheng Pharm Co Ltd (603998) has an Asset Resilience Ratio of 2.43% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Hunan Fangsheng Pharm Co Ltd (603998) defensive interval to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CN¥75.00 Million
≈ $10.97 Million USD Cash + Short-term Investments

Total Assets

CN¥3.09 Billion
≈ $452.38 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio of Hunan Fangsheng Pharm Co Ltd (2019–2023)

Asset resilience ratio of Hunan Fangsheng Pharm Co Ltd from 2019 to 2023. This chart shows how Hunan Fangsheng Pharm Co Ltd's Asset Resilience Ratio has changed over time. Read 603998 total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Hunan Fangsheng Pharm Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see balance sheet size of Hunan Fangsheng Pharm Co Ltd.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥75.00 Million 2.43%
Total Liquid Assets CN¥75.00 Million 2.43%

Asset Resilience Insights

  • Limited Liquidity: Hunan Fangsheng Pharm Co Ltd maintains only 2.43% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Hunan Fangsheng Pharm Co Ltd Industry Peers by Asset Resilience Ratio

Compare Hunan Fangsheng Pharm Co Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
Drug Manufacturers - Specialty & Generic 0.20%
Emcure Pharmaceuticals Ltd
NSE:EMCURE
Drug Manufacturers - Specialty & Generic 1.38%
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603
Drug Manufacturers - Specialty & Generic 9.04%
Chengdu Kanghong Pharmaceuticals Group Co Ltd
SHE:002773
Drug Manufacturers - Specialty & Generic 29.37%
Ajanta Pharma Limited
NSE:AJANTPHARM
Drug Manufacturers - Specialty & Generic 14.99%
Yipinhong Pharmaceutical Co Ltd Class A
SHE:300723
Drug Manufacturers - Specialty & Generic 1.01%
Luoxin Pharmaceuticals Group Stock Co Ltd
SHE:002793
Drug Manufacturers - Specialty & Generic 0.17%
Shaanxi Kanghui Pharm Co Ltd
SHG:603139
Drug Manufacturers - Specialty & Generic 0.01%

Hunan Fangsheng Pharm Co Ltd Asset Resilience Ratio by Year (2019–2023)

Hunan Fangsheng Pharm Co Ltd asset resilience ratio by year from 2019 to 2023. The table below shows the annual Asset Resilience Ratio data for Hunan Fangsheng Pharm Co Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2023-12-31 0.66% CN¥20.33 Million
≈ $2.97 Million
CN¥3.08 Billion
≈ $450.85 Million
-0.72pp
2022-12-31 1.38% CN¥40.31 Million
≈ $5.90 Million
CN¥2.92 Billion
≈ $427.60 Million
+0.81pp
2021-12-31 0.57% CN¥15.42 Million
≈ $2.26 Million
CN¥2.70 Billion
≈ $395.75 Million
+0.56pp
2020-12-31 0.01% CN¥296.24K
≈ $43.35K
CN¥2.24 Billion
≈ $328.19 Million
0.00pp
2019-12-31 0.01% CN¥287.48K
≈ $42.07K
CN¥1.99 Billion
≈ $291.92 Million
--
pp = percentage points

About Hunan Fangsheng Pharm Co Ltd

SHG:603998 China Drug Manufacturers - Specialty & Generic
Market Cap
$661.79 Million
CN¥4.52 Billion CNY
Market Cap Rank
#10510 Global
#2808 in China
Share Price
CN¥10.30
Change (1 day)
-1.06%
52-Week Range
CN¥8.85 - CN¥13.01
All Time High
CN¥18.09
About

Hunan Fangsheng Pharmaceutical Co., Ltd. engages in research, develops, produces, and sells traditional Chinese medicine industry and chemical pharmaceutical products in China. The company offers pharmaceutical manufacturing; and provides cardiovascular and cerebrovascular drugs, skeletal muscle system drugs, orthopedic drugs, respiratory drugs, pediatric drugs, neurological drugs, gynecological … Read more